| Barbara Neilan, MD | |
|
4701 Ogletown Stanton Rd, Suite 2400, Newark, DE 19713-2055 | |
| (302) 731-7782 | |
| (302) 738-5917 |
| Full Name | Barbara Neilan |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 4701 Ogletown Stanton Rd, Newark, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588614697 | NPI | - | NPPES |
| 000677161 | Medicaid | PA | |
| 092600200 | Medicaid | MD | |
| 0000988301 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | C10005770 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Neilan, MD 4701 Ogletown Stanton Rd, Suite 2400, Newark, DE 19713-2055 Ph: (302) 731-7782 | Barbara Neilan, MD 4701 Ogletown Stanton Rd, Suite 2400, Newark, DE 19713-2055 Ph: (302) 731-7782 |
News Archive
Beta blockers should be the first line of prevention against variceal bleeding in patients with cirrhosis and portal hypertension. While banding is similarly effective in reducing the incidence of such bleeding, it can have fatal complications and is more expensive.
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
New research shows that the more off-license stores a town boasts of, the greater the number of under-age drinkers who are likely to end up in hospital as a result of harmful drinking.
A new study by researchers at Rhode Island Hospital and Brown University finds that people with Alzheimer's Disease (AD) experienced more accidents and performed more poorly on road tests compared to drivers without cognitive impairment.
› Verified 3 days ago
Shruti Puri, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd Ste 5a43, Newark, DE 19718 Phone: 302-623-0188 Fax: 302-733-5640 | |
Zaid A Ammari, M.D. M.P.H. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 Fax: 347-851-8707 | |
Dr. Suresh Trivedi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 111 Continental Dr, Suite 406, Newark, DE 19713 Phone: 302-368-2630 Fax: 302-368-1271 | |
Dr. Bradley Bley, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1096 Old Churchmans Rd, Newark, DE 19713 Phone: 302-655-9494 Fax: 302-351-4898 | |
Dr. Avinash Chandra, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 86 Omega Dr, Omega Professional Center, Building B-86, Newark, DE 19713 Phone: 302-366-1929 Fax: 302-366-1006 | |
Dr. Lucinda Li, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd Ste 5a43, Newark, DE 19718 Phone: 302-623-0188 | |
Dr. James Robinson Mcninch Iv, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1148 |